000 01815 a2200469 4500
005 20250514072041.0
264 0 _c20040422
008 200404s 0 0 eng d
022 _a0049-3848
024 7 _a10.1016/s0049-3848(03)00243-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrueckmann, Martina
245 0 0 _aClinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure.
_h[electronic resource]
260 _bThrombosis research
_cMar 2003
300 _a259-63 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
650 0 4 _aAnticoagulants
_xpharmacology
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisseminated Intravascular Coagulation
_xprevention & control
650 0 4 _aDrainage
650 0 4 _aDrug Evaluation
650 0 4 _aDrug Therapy, Combination
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKnee Joint
_xsurgery
650 0 4 _aMultiple Organ Failure
_xblood
650 0 4 _aPostoperative Complications
_xblood
650 0 4 _aProtein C
_xpharmacology
650 0 4 _aRecombinant Proteins
_xpharmacology
650 0 4 _aRetropharyngeal Abscess
_xdrug therapy
650 0 4 _aSystemic Inflammatory Response Syndrome
_xcomplications
650 0 4 _aUrinary Catheterization
_xadverse effects
650 0 4 _aUrinary Tract Infections
_xcomplications
700 1 _aWizenmann, Jan
700 1 _aHoffmann, Ursula
700 1 _aSeeger, Markus
700 1 _aBewig, Burkhard
773 0 _tThrombosis research
_gvol. 109
_gno. 5-6
_gp. 259-63
856 4 0 _uhttps://doi.org/10.1016/s0049-3848(03)00243-3
_zAvailable from publisher's website
999 _c12601753
_d12601753